Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1977;55:394-400

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klotman, P. E.
Right arrow Articles by Judson, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klotman, P. E.
Right arrow Articles by Judson, W. E.

Circulation, Vol 55, 394-400, Copyright © 1977 by American Heart Association


ARTICLES

The effects of minoxidil on pulmonary and systemic hemodynamics in hypertensive man

PE Klotman, CE Grim, MH Weinberger and WE Judson

Pulmonary hypertension has been described as a possible complication of the antihypertensive vasodilator, minoxidil. A prospective study was undertaken in seven severely hypertensive patients refractory to multiple drug therapy. Treatment was initiated with fixed doses of hydrochlorothiazide (100 mg/day) and propranolol (160 mg/day) for a control period. Mean systemic arterial pressure, cardiac output, and pulmonary artery pressure were then compared before and after the addition of acute (5 day) and chronic (2 month) therapy with minoxidil. Mean arterial blood pressure decreased from a control value of 135 mm Hg to a value of 104 mm Hg acutely and 108 mm Hg chronically. Significant increases in mean cardiac output occurred with minoxidil therapy (from 4.2 L/min control to 5.4 L/min acutely and 5.1 L/min chronically) despite concomitant propranolol treatment. Mean pulmonary artery pressure did not increase either acutely or chronically. The data suggest that in patients with normal pulmonary hemodynamics prior to treatment, pulmonary hypertension does not develop during two months of minoxidil therapy.


This article has been cited by other articles:


Home page
Arch Intern MedHome page
M. Allon, W. D. Hall, and E. J. Macon
Prolonged Hypotension After Initial Minoxidil Dose
Arch Intern Med, October 1, 1986; 146(10): 2075 - 2076.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
M. A. Alpert and J. H. Bauer
Rapid Control of Severe Hypertension With Minoxidil
Arch Intern Med, November 1, 1982; 142(12): 2099 - 2104.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
S. L. LINAS and A. S. NIES
Minoxidil
Ann Intern Med, January 1, 1981; 94(1): 61 - 65.
[Abstract] [PDF]


Home page
JAMAHome page
M. E. Kosman
Evaluation of a New Antihypertensive Agent: Minoxidil
JAMA, July 4, 1980; 244(1): 73 - 75.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
C. E. Grim, F. C. Luft, C. M. Grim, P. E. Klotman, J. W. Van Huysse, and M. H. Weinberger
Rapid Blood Pressure Control With Minoxidil: Acute and Chronic Effects on Blood Pressure, Sodium Excretion, and the Renin-Aldosterone System
Arch Intern Med, May 1, 1979; 139(5): 529 - 533.
[Abstract] [PDF]


Home page
JAMAHome page
H. C. Mitchell and W. A. Pettinger
Long-Term Treatment of Refractory Hypertensive Patients With Minoxidil
JAMA, May 19, 1978; 239(20): 2131 - 2138.
[Abstract] [PDF]